Related Experiment Video
Updated: Jul 4, 2026

Knee Arthrocentesis in Adults
Published on: February 25, 2022
Juvenile Idiopathic Arthritis Registry at King Abdullah Specialized Children's Hospital (JIAR-KASCH) in Riyadh, Saudi
Jubran T Alqanatish1,2,3, Abdullah I Almojali1,2,3, Wejdan M Algbaiwi4
1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Insights
A new registry of juvenile idiopathic arthritis (JIA) cases at KASCH in Riyadh has been established, profiling epidemiology and treatment. This framework supports national pediatric rheumatology registries for better disease monitoring.
Area of Science:
- Pediatric Rheumatology
- Clinical Data Management
- Epidemiological Research
Background:
- Juvenile idiopathic arthritis (JIA) is a complex autoimmune disease requiring long-term management.
- Establishing comprehensive patient registries is crucial for understanding disease patterns and improving care.
- The King Abdullah Specialized Children's Hospital (KASCH) initiated a registry to capture JIA data.
Purpose of the Study:
- To create and maintain an up-to-date registry of juvenile idiopathic arthritis (JIA) cases.
- To detail the methodology employed in building the JIA registry.
- To provide insights into JIA epidemiology, clinical characteristics, and treatment in Saudi Arabia.
Main Methods:
- Retrospective and prospective data collection from August 2021.
- Utilized Hospital Information System and REDCap platform for data capture.
- Included sociodemographic, clinical, laboratory, imaging, and medication data for JIA patients at KASCH.
Main Results:
- The registry included 240 JIA patients by December 2024.
- Median age at presentation was 8 years, with 79% from central Saudi Arabia.
- Oligoarthritis (32.9%) and systemic JIA (25.8%) were common subtypes; anti-TNF agents were the most used biologics (62.5%).
Conclusions:
- The JIAR-KASCH registry offers a detailed profile of JIA in Saudi Arabia.
- The established framework can guide the development of national pediatric rheumatology registries.
- Facilitates robust data collection and long-term monitoring for JIA.
Objectives:
To establish and maintain a comprehensive, up-to-date registry of juvenile idiopathic arthritis (JIA) cases, and to outline the methodology used in creating it.
Methods:
Retrospective and prospective data collection commenced in August 2021, using the Hospital Information System to identify electronic medical records of JIA patients. All individuals diagnosed with JIA and receiving follow-up care at King Abdullah Specialized Children's Hospital (KASCH) in Riyadh were included. A broad range of variables covering sociodemographic characteristics, clinical features, laboratory results, imaging findings, and therapeutic medications were recorded in the REDCap platform. Data collection update occurs every 6 months.
Results:
By December 2024, the registry included 240 patients. The median age at presentation was 8 years (IQR: 4-11). Most patients (79%) were from the central region of Saudi Arabia, while the remainder were distributed across other regions. Oligoarthritis was the most common subtype (32.9%), followed by systemic JIA (25.8%). Among the biologic agents used to treat JIA, anti-TNF agents were the most frequently administered (62.5%), followed by anakinra (17%) and tocilizumab (13%).
Conclusion:
The JIAR-KASCH provides an in-depth profile of JIA epidemiology, clinical presentation, and management in Saudi Arabia. It also provides a framework that can guide the development of similar national registries, particularly in pediatric rheumatology, facilitating robust data collection and long-term disease monitoring.
Related Concept Videos
Knee Joint
A total of seven ligaments support the knee joint. The patellar ligament, which is also attached to the quadriceps femoris group...
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
